Physician profile
Mark J Swierzewski
NPI 1497705727
$2,222.31
in general payments reported to CMS, 2019-2025
29 companies · $675 in 2025
The $675 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $249 · 2021: $401 · 2022: $206 · 2023: $178 · 2024: $219 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $563.12 | 2019-2025 | Speedicath |
| Procept Biorobotics Corporation | $298.51 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $184.12 | 2019-2022 | |
| Medtronic, INC. | $158.67 | 2021 | |
| Teleflex LLC | $121.86 | 2024-2025 | Urolift |
| Boston Scientific Corporation | $121.68 | 2019-2022 | |
| Stability Biologics, LLC | $112.54 | 2020 | |
| Endo USA, INC. | $97.83 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $62.69 | 2021-2023 | Xiaflex |
| Janssen Biotech, INC. | $56.10 | 2019-2025 | Erleada |
| Hollister Incorporated | $38.71 | 2022-2023 | Vapro |
| Antares Pharma, INC. | $37.32 | 2022-2025 | Xyosted |
| Becton, Dickinson and Company | $32.49 | 2025 | Bard Urinary Drainage Bag, Aptra |
| Olympus America INC. | $29.79 | 2024 | Itind System |
| Mimedx Group, INC. | $29.49 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $27.91 | 2019-2025 | |
| 180 Medical, INC. | $26.85 | 2021 | |
| Tolmar, INC. | $25.33 | 2025 | Jatenzo, Eligard |
| Abbvie INC. | $23.30 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $23.17 | 2019 | |
| Bioprotect Medical, INC. | $22.85 | 2025 | Bioprotect Balloon Implant System |
| Blue Earth Diagnostics | $20.82 | 2025 | Posluma |
| Neotract INC. | $20.15 | 2019 | |
| Calyxo, INC. | $17.96 | 2025 | Cvac Aspiration System |
| Medtronic USA, INC. | $15.19 | 2019 | |
| Dentsply Ih Ab | $14.55 | 2023 | Lofric |
| Amgen INC. | $14.21 | 2019 | |
| Dentsply Ih INC. | $13.03 | 2022 | |
| Urogen Pharma, INC. | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Swierzewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.